Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001140361-25-027403
Filing Date
2025-07-25
Accepted
2025-07-25 18:12:52
Documents
1
Period of Report
2024-02-28

Document Format Files

Seq Description Document Type Size
1 FORM 4 form4.html 4  
1 FORM 4 form4.xml 4 6195
  Complete submission text file 0001140361-25-027403.txt   7694
Mailing Address 303A COLLEGE ROAD EAST PRINCETON NJ 08540
Business Address 303A COLLEGE ROAD EAST PRINCETON NJ 08540 800-208-3343
PDS Biotechnology Corp (Issuer) CIK: 0001472091 (see all company filings)

EIN.: 264231384 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 25B VREELAND ROAD SUITE 300 FLORHAM PARK NJ 07932
Business Address
Brown Spencer D. (Reporting) CIK: 0001930908 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37568 | Film No.: 251152658